See more : Metal Energy Corp. (MERG.V) Income Statement Analysis – Financial Results
Complete financial analysis of Belluscura plc (BELL.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Belluscura plc, a leading company in the Medical – Devices industry within the Healthcare sector.
- Moriya Corporation (1798.T) Income Statement Analysis – Financial Results
- Gatos Silver, Inc. (GATO) Income Statement Analysis – Financial Results
- Solid State plc (SOLI.L) Income Statement Analysis – Financial Results
- Tian Yuan Group Holdings Limited (6119.HK) Income Statement Analysis – Financial Results
- Shin Shin Natural Gas Company Limited (9918.TW) Income Statement Analysis – Financial Results
Belluscura plc (BELL.L)
About Belluscura plc
Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLO2R, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 825.41K | 1.40M | 420.32K | 0.00 | 128.70K | 245.55K | 333.39K | 43.02K |
Cost of Revenue | 5.03M | 1.33M | 472.49K | 0.00 | 114.39K | 252.87K | 346.01K | 33.29K |
Gross Profit | -4.20M | 68.11K | -52.17K | 0.00 | 14.32K | -7.32K | -12.62K | 9.73K |
Gross Profit Ratio | -509.22% | 4.87% | -12.41% | 0.00% | 11.12% | -2.98% | -3.79% | 22.62% |
Research & Development | 0.00 | 2.91M | 156.77K | 0.00 | 0.00 | 270.15K | 0.00 | 0.00 |
General & Administrative | 2.88M | 2.47M | 2.72M | 435.68K | 283.76K | 546.67K | 2.60M | 1.09M |
Selling & Marketing | 718.34K | 1.42M | 1.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 3.59M | 3.89M | 2.72M | 435.68K | 283.76K | 546.67K | 2.60M | 1.09M |
Other Expenses | 9.89M | 6.57M | 3.35M | 1.12M | 915.98K | 853.01K | 0.00 | 0.00 |
Operating Expenses | 13.49M | 10.47M | 6.08M | 1.56M | 1.20M | 1.40M | 2.60M | 986.53K |
Cost & Expenses | 18.52M | 11.80M | 6.55M | 1.56M | 1.31M | 1.65M | 2.94M | 1.02M |
Interest Income | 2.13K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 |
Interest Expense | 828.03K | 24.07K | 26.84K | 32.96K | 37.20K | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 3.30M | 3.06M | 269.35K | 8.54K | 107.45K | 437.77K | 10.32K | 14.03K |
EBITDA | -14.23M | -5.07M | -5.13M | -1.46M | -1.41M | -1.04M | -2.60M | -1.08M |
EBITDA Ratio | -1,724.43% | -319.26% | -1,219.79% | 0.00% | -1,127.97% | -254.34% | -780.24% | -2,501.03% |
Operating Income | -17.69M | -10.40M | -5.19M | -1.95M | -1.19M | -1.48M | -2.61M | -1.09M |
Operating Income Ratio | -2,143.39% | -743.66% | -1,233.99% | 0.00% | -921.07% | -601.98% | -783.34% | -2,533.63% |
Total Other Income/Expenses | -825.90K | -24.07K | -26.84K | -32.96K | -37.20K | 0.00 | 0.00 | 1.00 |
Income Before Tax | -18.52M | -8.15M | -5.21M | -1.98M | -1.55M | -1.48M | -2.61M | -976.80K |
Income Before Tax Ratio | -2,243.45% | -583.15% | -1,240.37% | 0.00% | -1,205.89% | -601.98% | -783.34% | -2,270.52% |
Income Tax Expense | 0.00 | 609.85K | -182.85K | 26.54K | -7.17K | -71.18K | 0.00 | 0.00 |
Net Income | -18.52M | -8.76M | -5.03M | -2.00M | -1.54M | -1.48M | -2.61M | -976.80K |
Net Income Ratio | -2,243.45% | -626.78% | -1,196.87% | 0.00% | -1,200.32% | -601.98% | -783.34% | -2,270.52% |
EPS | -0.14 | -0.07 | -0.05 | -0.02 | -0.01 | -0.01 | -0.04 | -0.21 |
EPS Diluted | -0.14 | -0.07 | -0.05 | -0.02 | -0.01 | -0.01 | -0.04 | -0.21 |
Weighted Avg Shares Out | 130.40M | 131.80M | 109.79M | 113.24M | 113.24M | 113.24M | 58.92M | 4.60M |
Weighted Avg Shares Out (Dil) | 130.40M | 131.80M | 109.79M | 113.24M | 113.24M | 113.24M | 58.92M | 4.60M |
Source: https://incomestatements.info
Category: Stock Reports